Literature DB >> 17640552

Fluorescence in situ hybridization in diagnostic cytology.

Kevin C Halling1, Benjamin R Kipp.   

Abstract

Fluorescence in situ hybridization (FISH) is a technique that uses fluorescently labeled DNA probes to detect chromosomal alterations in cells. FISH can detect various types of cytogenetic alterations including aneusomy (ie, abnormalities of chromosome copy number), duplication, amplification, deletion, and translocation. Because tumor cells generally contain chromosomal alterations, FISH is able to detect cells that have chromosomal abnormalities consistent with neoplasia in exfoliative and aspiration cytology specimens. This review will discuss the utility of FISH for the detection of bladder, lung, pancreatobiliary, and esophageal carcinoma in cytologic specimens.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17640552     DOI: 10.1016/j.humpath.2007.04.015

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  31 in total

1.  A potential probe set of fluorescence in situ hybridization for detection of lung cancer in bronchial brushing specimens.

Authors:  Yi-Zhen Liu; Zhen Wang; Li-Li Fang; Lu Li; Jian Cao; Xin Xu; Ya-Ling Han; Yan Cai; Liang-Xu Wang; Ming-Rong Wang
Journal:  J Cancer Res Clin Oncol       Date:  2012-04-27       Impact factor: 4.553

Review 2.  Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.

Authors:  Boris Blechacz; Gregory J Gores
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

3.  Quantitative analysis of centromeric FISH spots during the cell cycle by image cytometry.

Authors:  Genta Amakawa; Kenzo Ikemoto; Hideaki Ito; Tomoko Furuya; Kohsuke Sasaki
Journal:  J Histochem Cytochem       Date:  2013-07-04       Impact factor: 2.479

4.  Differentiation of malignant and benign proximal bile duct strictures: the diagnostic dilemma.

Authors:  Jaap Jacob Kloek; Otto Marinus van Delden; Deha Erdogan; Fibo Jan ten Kate; Erik Anthoni Rauws; Olivier-Robert Busch; Dirk Joan Gouma; Thomas Mathijs van Gulik
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

5.  Hilar cholangiocarcinoma: expert consensus statement.

Authors:  John C Mansour; Thomas A Aloia; Christopher H Crane; Julie K Heimbach; Masato Nagino; Jean-Nicolas Vauthey
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

6.  Genetic diagnosis of patients with esophageal cancer using FISH.

Authors:  Idiris Awut; Madiniyet Niyaz; Xie Huizhong; Hadeti Biekemitoufu; Zhang Hong Yan; Zhang Zhu; Ilyar Sheyhedin; Zhang Changmin; Zhangli Wei; Wen Hao
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

7.  Copy-number analysis of topoisomerase and thymidylate synthase genes in frozen and FFPE DNAs of colorectal cancers.

Authors:  Jinsheng Yu; Ryan Miller; Wanghai Zhang; Mala Sharma; Vicky Holtschlag; Mark A Watson; Howard L McLeod
Journal:  Pharmacogenomics       Date:  2008-10       Impact factor: 2.533

8.  Fluorescence imaging of single-copy DNA sequences within the human genome using PNA-directed padlock probe assembly.

Authors:  Anastasia I Yaroslavsky; Irina V Smolina
Journal:  Chem Biol       Date:  2013-03-21

9.  Determination of HER-2 status on FNAC material from breast carcinomas using in situ hybridization with dual chromogen visualization with silver enhancement (dual SISH).

Authors:  Elsa Beraki; Torill Sauer
Journal:  Cytojournal       Date:  2010-10-11       Impact factor: 2.091

10.  Gene amplification of EGFR and its clinical significance in various cervical (lesions) lesions using cytology and FISH.

Authors:  Qing Li; Xue Cheng; Jie Ji; Jingmin Zhang; Xiaojun Zhou
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.